Cargando…
Risk of myeloid neoplasms after solid organ transplantation
Solid organ transplant recipients have elevated cancer risks, due in part to pharmacologic immunosuppression. However, little is known about risks for hematologic malignancies of myeloid origin. We linked the US Scientific Registry of Transplant Recipients with 15 population-based cancer registries...
Autores principales: | Morton, Lindsay M., Gibson, Todd M., Clarke, Christina A., Lynch, Charles F., Anderson, Lesley A., Pfeiffer, Ruth, Landgren, Ola, Weisenburger, Dennis D., Engels, Eric A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197126/ https://www.ncbi.nlm.nih.gov/pubmed/24727673 http://dx.doi.org/10.1038/leu.2014.132 |
Ejemplares similares
-
Risk of lymphoma subtypes after solid organ transplantation in the United States
por: Clarke, C A, et al.
Publicado: (2013) -
Risk of Rare Cancers Among Solid Organ Transplant Recipients
por: D’Arcy, Monica E, et al.
Publicado: (2020) -
Risks of myeloid malignancies in patients with autoimmune conditions
por: Anderson, L A, et al.
Publicado: (2009) -
PB1910: CHRONIC MYELOID LEUKEMIA AND RELATIONSHIP TO SECONDARY SOLID NEOPLASMS
por: Ramos, M. J., et al.
Publicado: (2022) -
Extracellular Vesicles in Myeloid Neoplasms
por: Karantanou, Christina, et al.
Publicado: (2022)